study for evaluation of 18F-choline PET/CT efficacy in patients with prostate carcinoma. - ND
- Conditions
- patient with prostate carcinomaMedDRA version: 12.1Level: LLTClassification code 10036921Term: Prostate carcinoma
- Registration Number
- EUCTR2010-021501-20-IT
- Lead Sponsor
- ISTITUTO NEUROLOGICO MEDITERRANEO NEUROMED
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
- Histologically proven prostate carcinoma
- PSA rising serum levels
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Histologically proven prostate carcinoma
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method